ETR:FME - Fresenius Medical Care Stock Price, Price Target & More

€81.06 -1.72 (-2.08 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close€81.06
Today's Range€80.48 - €82.44
52-Week Range€75.53 - €93.82
Volume678,613 shs
Average Volume704,197 shs
Market Capitalization$25.25 billion
P/E RatioN/A
Dividend Yield1.29%
BetaN/A

About Fresenius Medical Care (ETR:FME)

Fresenius Medical Care logoFresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FME News and Ratings via Email

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
SymbolETR:FME
CUSIPN/A
Phone+49-6172-6090

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins8.56%
Return on Equity12.84%
Return on Assets6.08%

Miscellaneous

EmployeesN/A
Outstanding Shares306,960,000

How to Become a New Pot Stock Millionaire

Fresenius Medical Care (ETR:FME) Frequently Asked Questions

What is Fresenius Medical Care's stock symbol?

Fresenius Medical Care trades on the ETR under the ticker symbol "FME."

What price target have analysts set for FME?

21 equities research analysts have issued 1-year target prices for Fresenius Medical Care's stock. Their predictions range from €82.00 to €107.00. On average, they anticipate Fresenius Medical Care's share price to reach €93.24 in the next twelve months. View Analyst Ratings for Fresenius Medical Care.

Who are some of Fresenius Medical Care's key competitors?

Who are Fresenius Medical Care's key executives?

Fresenius Medical Care's management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56)

Has Fresenius Medical Care been receiving favorable news coverage?

News headlines about FME stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Fresenius Medical Care earned a media sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the company an impact score of 46.03 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

What is Fresenius Medical Care's stock price today?

One share of FME stock can currently be purchased for approximately €81.06.

How big of a company is Fresenius Medical Care?

Fresenius Medical Care has a market capitalization of $25.25 billion.

How can I contact Fresenius Medical Care?

Fresenius Medical Care's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.


MarketBeat Community Rating for Fresenius Medical Care (FME)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  646 (Vote Outperform)
Underperform Votes:  446 (Vote Underperform)
Total Votes:  1,092
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fresenius Medical Care (ETR:FME) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
21 Wall Street analysts have issued ratings and price targets for Fresenius Medical Care in the last 12 months. Their average twelve-month price target is €93.24The high price target for FME is €107.00 and the low price target for FME is €82.00. There are currently 9 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.572.552.502.44
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €93.24€93.18€90.57€88.56

Fresenius Medical Care (ETR:FME) Consensus Price Target History

Price Target History for Fresenius Medical Care (ETR:FME)

Fresenius Medical Care (ETR:FME) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/25/2018Jefferies GroupSet Price TargetNeutral€84.00View Rating Details
4/24/2018Nord/LBSet Price TargetBuy€93.00View Rating Details
4/24/2018Deutsche BankSet Price TargetBuy€102.00View Rating Details
4/23/2018Warburg ResearchSet Price TargetNeutral€85.00View Rating Details
4/23/2018Kepler Capital MarketsSet Price TargetBuy€100.00View Rating Details
4/23/2018CommerzbankSet Price TargetNeutral€82.00View Rating Details
4/23/2018Credit Suisse GroupSet Price TargetBuy€96.00View Rating Details
4/23/2018Berenberg BankSet Price TargetBuy€101.00View Rating Details
4/23/2018Independent ResearchSet Price TargetNeutral€90.00View Rating Details
4/23/2018JPMorgan ChaseSet Price TargetBuy€96.10View Rating Details
3/26/2018HSBCSet Price TargetNeutral€89.00View Rating Details
3/9/2018BarclaysSet Price TargetNeutral€90.00View Rating Details
2/28/2018CfraSet Price TargetBuy€97.00View Rating Details
2/27/2018UBSSet Price TargetNeutral€87.00View Rating Details
2/27/2018Goldman SachsSet Price TargetBuy€97.00View Rating Details
2/12/2018CitigroupSet Price TargetBuy€92.00View Rating Details
1/31/2018DZ BankSet Price TargetBuy€107.00View Rating Details
12/11/2017Morgan StanleySet Price TargetNeutral€90.00View Rating Details
11/6/2017S&P GlobalSet Price TargetBuy€95.00View Rating Details
7/20/2017Oddo SecuritiesSet Price TargetBuy€95.00View Rating Details
5/5/2017Societe GeneraleSet Price TargetNeutral€90.00View Rating Details
10/27/2016Bankhaus LampeSet Price TargetNeutral€80.00View Rating Details
10/27/2016S&P GlobalSet Price TargetNeutral€81.00View Rating Details
8/3/2016BNP ParibasSet Price TargetNeutral€80.00View Rating Details
8/2/2016Baader BankSet Price TargetBuy€90.00View Rating Details
6/27/2016Sanford C. BernsteinSet Price TargetBuy€92.00View Rating Details
5/24/2016Bank of AmericaSet Price TargetBuy€94.00View Rating Details
(Data available from 4/25/2016 forward)

Earnings

Dividends

Fresenius Medical Care (ETR:FME) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Fresenius Medical Care (ETR FME) Insider Trading and Institutional Ownership History

Insider Trading History for Fresenius Medical Care (ETR:FME)

Fresenius Medical Care (ETR FME) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Fresenius Medical Care (ETR FME) News Headlines

Source:
DateHeadline
Fresenius Medical Care (FME) Given a €84.00 Price Target at Jefferies GroupFresenius Medical Care (FME) Given a €84.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 25 at 9:22 AM
Fresenius Medical Care (FME) Given a €93.00 Price Target by Nord/LB AnalystsFresenius Medical Care (FME) Given a €93.00 Price Target by Nord/LB Analysts
www.americanbankingnews.com - April 24 at 12:16 PM
Fresenius Medical Care (FME) Given a €102.00 Price Target by Deutsche Bank AnalystsFresenius Medical Care (FME) Given a €102.00 Price Target by Deutsche Bank Analysts
www.americanbankingnews.com - April 24 at 11:34 AM
Kepler Capital Markets Analysts Give Fresenius Medical Care (FME) a €100.00 Price TargetKepler Capital Markets Analysts Give Fresenius Medical Care (FME) a €100.00 Price Target
www.americanbankingnews.com - April 23 at 8:12 AM
Fresenius Medical Care (FME) Given a €85.00 Price Target at Warburg ResearchFresenius Medical Care (FME) Given a €85.00 Price Target at Warburg Research
www.americanbankingnews.com - April 23 at 8:12 AM
Fresenius Medical Care (FME) Given a €96.10 Price Target by JPMorgan Chase AnalystsFresenius Medical Care (FME) Given a €96.10 Price Target by JPMorgan Chase Analysts
www.americanbankingnews.com - April 23 at 7:08 AM
Fresenius Medical Care (FME) PT Set at €101.00 by Berenberg BankFresenius Medical Care (FME) PT Set at €101.00 by Berenberg Bank
www.americanbankingnews.com - April 23 at 6:30 AM
Independent Research Analysts Give Fresenius Medical Care (FME) a €90.00 Price TargetIndependent Research Analysts Give Fresenius Medical Care (FME) a €90.00 Price Target
www.americanbankingnews.com - April 23 at 6:30 AM
Fresenius Medical Care (FME) Given a €82.00 Price Target by Commerzbank AnalystsFresenius Medical Care (FME) Given a €82.00 Price Target by Commerzbank Analysts
www.americanbankingnews.com - April 23 at 6:30 AM
Credit Suisse Group Analysts Give Fresenius Medical Care (FME) a €96.00 Price TargetCredit Suisse Group Analysts Give Fresenius Medical Care (FME) a €96.00 Price Target
www.americanbankingnews.com - April 23 at 6:30 AM
Fresenius Medical Care (FME) Receives Consensus Rating of "Buy" from BrokeragesFresenius Medical Care (FME) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 22 at 5:32 PM
Fresenius Medical sells U.S. Sound Inpatient for $2.15 billionFresenius Medical sells U.S. Sound Inpatient for $2.15 billion
finance.yahoo.com - April 21 at 9:35 AM
JPMorgan Chase Reiterates "€106.40" Price Target for Fresenius Medical Care (FME)JPMorgan Chase Reiterates "€106.40" Price Target for Fresenius Medical Care (FME)
www.americanbankingnews.com - April 20 at 10:18 PM
Fresenius Medical Care (FME) Given a €98.00 Price Target at Goldman SachsFresenius Medical Care (FME) Given a €98.00 Price Target at Goldman Sachs
www.americanbankingnews.com - April 16 at 10:54 PM
Berenberg Bank Analysts Give Fresenius Medical Care (FME) a €92.10 Price TargetBerenberg Bank Analysts Give Fresenius Medical Care (FME) a €92.10 Price Target
www.americanbankingnews.com - April 15 at 11:10 PM
Fresenius Medical Care (FME) Given a €95.00 Price Target by S&P Global AnalystsFresenius Medical Care (FME) Given a €95.00 Price Target by S&P Global Analysts
www.americanbankingnews.com - April 14 at 3:07 PM
Fresenius Medical Care (FME) Given a €98.00 Price Target by Goldman Sachs AnalystsFresenius Medical Care (FME) Given a €98.00 Price Target by Goldman Sachs Analysts
www.americanbankingnews.com - April 14 at 12:53 PM
Jefferies Group Analysts Give Fresenius Medical Care (FME) a €83.00 Price TargetJefferies Group Analysts Give Fresenius Medical Care (FME) a €83.00 Price Target
www.americanbankingnews.com - April 14 at 11:15 AM
Fresenius Medical Care (FME) Given a €88.00 Price Target by Independent Research AnalystsFresenius Medical Care (FME) Given a €88.00 Price Target by Independent Research Analysts
www.americanbankingnews.com - April 14 at 11:15 AM
Deutsche Bank Analysts Give Fresenius Medical Care (FME) a €85.00 Price TargetDeutsche Bank Analysts Give Fresenius Medical Care (FME) a €85.00 Price Target
www.americanbankingnews.com - April 14 at 10:05 AM
Fresenius Medical Care (FME) PT Set at €92.10 by Berenberg BankFresenius Medical Care (FME) PT Set at €92.10 by Berenberg Bank
www.americanbankingnews.com - April 13 at 12:24 AM
Fresenius Medical Care (FME) Given a €84.00 Price Target at Deutsche BankFresenius Medical Care (FME) Given a €84.00 Price Target at Deutsche Bank
www.americanbankingnews.com - April 12 at 11:52 PM
Fresenius Medical Care (FME) Given a €88.00 Price Target at Independent ResearchFresenius Medical Care (FME) Given a €88.00 Price Target at Independent Research
www.americanbankingnews.com - April 12 at 11:52 PM
Goldman Sachs Analysts Give Fresenius Medical Care (FME) a €97.00 Price TargetGoldman Sachs Analysts Give Fresenius Medical Care (FME) a €97.00 Price Target
www.americanbankingnews.com - April 12 at 10:46 PM
JPMorgan Chase Analysts Give Fresenius Medical Care (FME) a €95.10 Price TargetJPMorgan Chase Analysts Give Fresenius Medical Care (FME) a €95.10 Price Target
www.americanbankingnews.com - April 12 at 9:35 PM
Citigroup Analysts Give Fresenius Medical Care (FME) a €92.00 Price TargetCitigroup Analysts Give Fresenius Medical Care (FME) a €92.00 Price Target
www.americanbankingnews.com - April 12 at 9:35 PM
Berenberg Bank Analysts Give Fresenius Medical Care (FME) a €95.60 Price TargetBerenberg Bank Analysts Give Fresenius Medical Care (FME) a €95.60 Price Target
www.americanbankingnews.com - April 9 at 2:58 PM
JPMorgan Chase Reiterates €95.10 Price Target for Fresenius Medical Care (FME)JPMorgan Chase Reiterates €95.10 Price Target for Fresenius Medical Care (FME)
www.americanbankingnews.com - April 7 at 2:46 PM
Fresenius Medical Care (FME) PT Set at €95.60 by Berenberg BankFresenius Medical Care (FME) PT Set at €95.60 by Berenberg Bank
www.americanbankingnews.com - April 5 at 7:58 PM
Goldman Sachs Reiterates €97.00 Price Target for Fresenius Medical Care (FME)Goldman Sachs Reiterates €97.00 Price Target for Fresenius Medical Care (FME)
www.americanbankingnews.com - April 4 at 1:53 PM
Kepler Capital Markets Analysts Give Fresenius Medical Care (FME) a €95.00 Price TargetKepler Capital Markets Analysts Give Fresenius Medical Care (FME) a €95.00 Price Target
www.americanbankingnews.com - April 2 at 7:17 AM
Fresenius Medical Care (FME) Given a €97.00 Price Target by Goldman Sachs AnalystsFresenius Medical Care (FME) Given a €97.00 Price Target by Goldman Sachs Analysts
www.americanbankingnews.com - April 1 at 9:47 PM
S&P Global Analysts Give Fresenius Medical Care (FME) a €95.00 Price TargetS&P Global Analysts Give Fresenius Medical Care (FME) a €95.00 Price Target
www.americanbankingnews.com - April 1 at 7:35 PM
JPMorgan Chase & Co. Reiterates €95.60 Price Target for Fresenius Medical Care (FME)JPMorgan Chase & Co. Reiterates €95.60 Price Target for Fresenius Medical Care (FME)
www.americanbankingnews.com - March 30 at 8:24 PM
Fresenius Medical Care (FME) PT Set at €87.00 by UBSFresenius Medical Care (FME) PT Set at €87.00 by UBS
www.americanbankingnews.com - March 30 at 7:18 PM
JPMorgan Chase & Co. Analysts Give Fresenius Medical Care (FME) a €95.60 Price TargetJPMorgan Chase & Co. Analysts Give Fresenius Medical Care (FME) a €95.60 Price Target
www.americanbankingnews.com - March 29 at 5:48 PM
Fresenius Medical Care (FME) Given Average Recommendation of "Buy" by BrokeragesFresenius Medical Care (FME) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 28 at 5:40 PM
Fresenius Medical Care (FME) Given a €96.10 Price Target by JPMorgan Chase & Co. AnalystsFresenius Medical Care (FME) Given a €96.10 Price Target by JPMorgan Chase & Co. Analysts
www.americanbankingnews.com - March 28 at 10:27 AM
Fresenius Medical Care (FME) Given a €89.00 Price Target at HSBCFresenius Medical Care (FME) Given a €89.00 Price Target at HSBC
www.americanbankingnews.com - March 26 at 8:36 AM
Fresenius Medical Care (FME) Given a €97.00 Price Target at Goldman SachsFresenius Medical Care (FME) Given a €97.00 Price Target at Goldman Sachs
www.americanbankingnews.com - March 24 at 11:12 PM
UBS Reiterates €87.00 Price Target for Fresenius Medical Care (FME)UBS Reiterates €87.00 Price Target for Fresenius Medical Care (FME)
www.americanbankingnews.com - March 24 at 10:01 PM
Fresenius Medical Care (FME) Given a €96.00 Price Target at Credit Suisse GroupFresenius Medical Care (FME) Given a €96.00 Price Target at Credit Suisse Group
www.americanbankingnews.com - March 24 at 6:46 PM
3 Reasons Why You Should Invest in Fresenius Medical Now3 Reasons Why You Should Invest in Fresenius Medical Now
finance.yahoo.com - March 22 at 10:00 AM
The Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and OlympusThe Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and Olympus
finance.yahoo.com - March 21 at 10:58 AM
Fresenius Medical Care AG & Co. KGaA (FME) Given a €100.00 Price Target at Kepler Capital MarketsFresenius Medical Care AG & Co. KGaA (FME) Given a €100.00 Price Target at Kepler Capital Markets
www.americanbankingnews.com - March 16 at 2:54 PM
Barclays Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €90.00 Price TargetBarclays Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €90.00 Price Target
www.americanbankingnews.com - March 9 at 9:33 AM
Fresenius Medical Care AG & Co. KGaA (FME) Given a €82.00 Price Target by Commerzbank AnalystsFresenius Medical Care AG & Co. KGaA (FME) Given a €82.00 Price Target by Commerzbank Analysts
www.americanbankingnews.com - March 8 at 9:51 AM
Fresenius Medical Care AG & Co. KGaA (FME) Given a €101.00 Price Target at Berenberg BankFresenius Medical Care AG & Co. KGaA (FME) Given a €101.00 Price Target at Berenberg Bank
www.americanbankingnews.com - March 6 at 12:18 AM
Fresenius Medical Care AG & Co. KGaA (FME) Receives Average Recommendation of "Buy" from BrokeragesFresenius Medical Care AG & Co. KGaA (FME) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 3 at 5:38 PM
Fresenius Medical Care AG & Co. KGaA (FME) Given a €92.00 Price Target at Independent ResearchFresenius Medical Care AG & Co. KGaA (FME) Given a €92.00 Price Target at Independent Research
www.americanbankingnews.com - February 28 at 9:06 PM

SEC Filings

Fresenius Medical Care (ETR:FME) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Fresenius Medical Care (ETR FME) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.